Cipher Pharmaceuticals vs Tilray
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Cipher Pharmaceuticals and Tilray are worth about the same: $236 M and $241 M (market caps of Oct 31, 2026).
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Cipher Pharmaceuticals CPH.TO · #15,674 in the world | Tilray TLRY · #15,603 in the world |
|---|---|---|
| Profile | ||
| Country | 🇨🇦 Canada | 🇨🇦 Canada |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | — | 2013 |
| Size | ||
| Market cap | $236 M | $241 M |
| Revenue | — | $915 M |
| Net income | — | $-121 M |
| Employees | — | 1,030 |
| Valuation | ||
| Price to sales | — | 0.3× |
| Price to book | — | 0.1× |
| Free cash flow yield | — | -52.8% |
| Profitability | ||
| Gross margin | — | 28.4% |
| Operating margin | — | -6.9% |
| Net margin | — | -13.3% |
| Return on equity | — | -7.8% |
| Growth | ||
| Revenue growth | — | 11.5% |
| Revenue growth, 3 years a year | — | 13.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Interest cover | — | -2.1× |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Oct 2026 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Cipher Pharmaceuticals or Tilray?
Cipher Pharmaceuticals and Tilray are worth about the same: $236 M and $241 M (market caps of Oct 31, 2026).
More about Cipher Pharmaceuticals
More about Tilray
Sources#
Every figure on this page comes from these, with the date shown next to it.